Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

INDUSTRY × Menorrhagia × linzagolix × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 4 Menorrhagia 2

Interventions

estradiol, norethindrone drug combination 6 elagolix 6 asoprisnil 6 Estradiol 5 vilaprisan 4 Norethindrone Acetate 4 relugolix 3 Uterine Myomectomy 3 linzagolix 2 Uterine Artery Embolization 2 ulipristal 1 Radiofrequency Ablation 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Electrocoagulation 1 Cryosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03070899 2021-06-09

PRIMROSE 1

ObsEva SA

Phase 3 Completed

Leiomyoma, Menorrhagia

NCT03070951 2021-03-05

PRIMROSE 2

ObsEva SA

Phase 3 Completed

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡